BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 322.00
-23.00 (-6.67%)
Aug 26, 2026, 5:29 PM CET
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,002 | 1,999 | 257.35 | 616 | 228.29 | 23.15 |
Other Revenue | - | - | - | - | 1.14 | 2.52 |
| 1,002 | 1,999 | 257.35 | 616 | 229.43 | 25.66 | |
Revenue Growth | -46.09% | 676.80% | -58.22% | 168.49% | 794.02% | -60.64% |
Cost of Revenue | 68.52 | 59.22 | 26.98 | 14.99 | 74.33 | 55.07 |
Gross Profit | 933.97 | 1,940 | 230.37 | 601.01 | 155.11 | -29.4 |
Selling, General & Admin | 210.59 | 194.83 | 148.84 | 172.18 | 148.67 | 97.35 |
Research & Development | 501.57 | 376.92 | 311.15 | 172.14 | - | - |
Other Operating Expenses | -12.69 | -0.1 | - | -0.27 | -0.25 | -0.01 |
Operating Expenses | 699.47 | 571.65 | 459.99 | 344.05 | 163.04 | 110.45 |
Operating Income | 234.5 | 1,368 | -229.62 | 256.96 | -7.94 | -139.85 |
Interest Expense | - | -2.03 | - | -0.33 | -0.56 | -0.84 |
Interest & Investment Income | 75.68 | 34.68 | 40.85 | 34.23 | 2.54 | - |
Currency Exchange Gain (Loss) | -61.23 | -144.99 | -0.75 | -14.32 | -5.01 | 0.33 |
Other Non Operating Income (Expenses) | -0.33 | -0.33 | 0 | -0.05 | -0.19 | -0.15 |
EBT Excluding Unusual Items | 248.63 | 1,256 | -189.52 | 276.49 | -11.17 | -140.5 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.01 |
Pretax Income | 248.63 | 1,256 | -189.52 | 276.49 | -11.17 | -140.51 |
Income Tax Expense | 143.11 | 233.26 | -12.44 | 47.24 | 0.01 | -20.72 |
Net Income | 105.52 | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 |
Net Income to Common | 105.52 | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 |
Net Income Growth | -90.11% | - | - | - | - | - |
Shares Outstanding (Basic) | 89 | 89 | 88 | 88 | 88 | 88 |
Shares Outstanding (Diluted) | 89 | 89 | 89 | 88 | 89 | 88 |
Shares Change | 0.12% | 0.23% | 0.04% | -0.22% | 0.71% | - |
EPS (Basic) | 1.19 | 11.55 | -2.00 | 2.60 | -0.13 | -1.36 |
EPS (Diluted) | 1.18 | 11.52 | -2.00 | 2.59 | -0.13 | -1.36 |
EPS Growth | -90.14% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 233.73 | 1,421 | -342.97 | 302.25 | -44.38 | -144.84 |
Free Cash Flow Per Share | 2.63 | 16.01 | -3.87 | 3.42 | -0.50 | -1.65 |
Dividend Per Share | 2.000 | 2.000 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 93.16% | 97.04% | 89.52% | 97.57% | 67.60% | -114.58% |
Operating Margin | 23.39% | 68.44% | -89.22% | 41.71% | -3.46% | -544.96% |
Profit Margin | 10.53% | 51.14% | -68.81% | 37.22% | -4.87% | -466.78% |
Free Cash Flow Margin | 23.32% | 71.07% | -133.27% | 49.07% | -19.35% | -564.40% |
EBITDA | - | - | -211.19 | 275.39 | -1.87 | -134.72 |
EBITDA Margin | - | - | -82.06% | 44.71% | -0.82% | - |
D&A For EBITDA | - | - | 18.43 | 18.43 | 6.07 | 5.13 |
EBIT | 234.5 | 1,368 | -229.62 | 256.96 | -7.94 | -139.85 |
EBIT Margin | 23.39% | 68.44% | -89.22% | 41.71% | -3.46% | - |
Effective Tax Rate | 57.56% | 18.58% | - | 17.09% | - | - |
Revenue as Reported | - | - | - | - | -228.63 | 26.69 |